doi:10.1186/1741-7015-11-205, PMID: 24229326 Morris G, Maes M (2014) Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways
Currently, no dietary supplement patch has been approved by the FDA for weight loss or to manage obesity
While research is continuing, investigators have explored how the peptide may influence tissue repair, blood vessel formation, inflammation, and cellular signaling involved in recovery
Semaglutide can cause nausea and GI upset
Individualized management remains appropriate for higher-risk patients, including those with gastroparesis, Parkinsons disease, recent GLP-1 dose escalation, or compounded formulations